Genus Sophora: a comprehensive review on secondary chemical metabolites and their biological aspects from past achievements to future perspectives

Arch Pharm Res. 2021 Nov;44(11):903-986. doi: 10.1007/s12272-021-01354-2. Epub 2021 Dec 15.

Abstract

Sophora is deemed as one of the most remarkable genera of Fabaceae, and the third largest family of flowering plants. The genus Sophora comprises approximately 52 species, 19 varieties, and 7 forms that are widely distributed in Asia and mildly in Africa. Sophora species are recognized to be substantial sources of broad spectrum biopertinent secondary metabolites namely flavonoids, isoflavonoids, chalcones, chromones, pterocarpans, coumarins, benzofuran derivatives, sterols, saponins (mainly triterpene glycosides), oligostilbenes, and mainly alkaloids. Meanwhile, extracts and isolated compounds from Sophora have been identified to possess several health-promising effects including anti-inflammatory, anti-arthritic, antiplatelets, antipyretic, anticancer, antiviral, antimicrobial, antioxidant, anti-osteoporosis, anti-ulcerative colitis, antidiabetic, anti-obesity, antidiarrheal, and insecticidal activities. Herein, the present review aims to provide comprehensive details about the phytochemicals and biological effects of Sophora species. The review spotlighted on the promising phytonutrients extracted from Sophora and their plethora of bioactivities. The review also clarifies the remaining gaps and thus qualifies and supplies a platform for further investigations of these compounds.

Keywords: Biological activities; Distinctive-alkaloids; Fabaceae; Phytochemicals; Sophora.

Publication types

  • Review

MeSH terms

  • Drug Development
  • Humans
  • Phytochemicals / metabolism
  • Phytochemicals / pharmacology*
  • Phytochemicals / therapeutic use
  • Secondary Metabolism
  • Sophora / chemistry
  • Sophora / metabolism*

Substances

  • Phytochemicals